Meta-analytic review of the clinical effectiveness of oral deferiprone (L1) A. AddisR. LoebsteinT. R. Einarson CLINICAL TRIALS Pages: 1 - 6
Nasal decongestion with imidazoline derivatives: acoustic rhinometry measurements W. HochbanH. AlthoffA. Ziegler CLINICAL TRIALS Pages: 7 - 12
Laboratory data in healthy volunteers: reference values, reference changes, screening and laboratory adverse event limits in Phase I clinical trials M. SibilleN. DeigatD. Vital Durand CLINICAL TRIALS Pages: 13 - 19
CYP2D6 polymorphism in systemic lupus erythematosus patients S. KortunayA. BozkurtS. Oğuz Kayaalp PHARMACODYNAMICS Pages: 21 - 25
A double-blind study of MPV-2213ad, a novel aromatase inhibitor, in healthy male subjects O. AhokoskiK. IrjalaR. Huupponen PHARMACODYNAMICS Pages: 27 - 34
Effects of general anaesthetic procedures on mitochondrial function of human skeletal muscle Ò. MiróA. BarrientosF. Cardellach PHARMACODYNAMICS Pages: 35 - 41
CYP2C19 genotypes and omeprazole metabolism after single and repeated dosing when combined with clarithromycin Q. ZhouI. YamamotoJ. Azuma PHARMACOKINETICS AND DISPOSITION Pages: 43 - 47
Pharmacokinetics of oxypolygelatine in healthy volunteers P. A. ThürmannR. LissnerS. Harder PHARMACOKINETICS AND DISPOSITION Pages: 49 - 51
Systemic exposure to rosiglitazone is unaltered by food M. I. FreedA. AllenR. A. DiCicco PHARMACOKINETICS AND DISPOSITION Pages: 53 - 56
The effect of ketoconazole on the pharmacokinetics, pharmacodynamics and safety of nisoldipine R. HeinigH. G. AdelmannG. Ahr PHARMACOKINETICS AND DISPOSITION Pages: 57 - 60
Pharmacokinetics and pharmacodynamics of clevidipine in healthy volunteers after intravenous infusion H. EricssonC. FaktC. G. Regårdh PHARMACOKINETICS AND DISPOSITION Pages: 61 - 67
Utilization of cardiovascular drugs (blood pressure lowering drugs, lipid lowering drugs and nitrates) and mortality from ischaemic heart disease and stroke An ecological analysis based on Sweden's municipalities J. MerloG. LindbergA. Melander PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 69 - 76
Population pharmacokinetic analysis of pirmenol in healthy volunteers and patients with arrhythmia H. KasaiK. UenoM. Shibakawa LETTER TO THE EDITORS Pages: 77 - 78
Lack of kinetic interaction between digoxin and voglibose M. KusumotoK. UenoM. Shibakawa LETTER TO THE EDITORS Pages: 79 - 80
Outpatient use pattern for ketorolac is distinct from comparator drugs Samuel ErnyHilal Maradit LETTER TO THE EDITORS Pages: 81 - 81
To the letter to the editors by S. Erny and H. Maradit. Outpatient use pattern for ketorolac is distinct from comparator drugs F. Menniti-IppolitoM. MagginiA. M. Walker REPLY Pages: 83 - 83
